kfa670,
For me, not an unexpected reality hence never a panic and a choice to ride it out which was a choice each investor in at the time needed to make for themselves without pointing to anyone else about their decision which has been Maverick’s contention since 2015.
Some of my early posts pointed to a DNDN and Deep Capture type of situation with NWBO. My early posts on Seeking Alpha equated big pharma to the Titanic and NWBO to the iceberg. They would have some time to see it, take evasive action and many go down with the ship anyway. If not for Sawston real estate appreciation the $.05 potential price I shared might have been achieved. I shared that price target after Mr. Woodford bailed but before we went to $.14 even though I had hoped for better price stability with Mr. Woodford on board prior to his exit just like Linda did. We all know how that turned out. I had hoped for a 20 year from inception time frame for results which seemed typical for some immunotherapies but always said I was in to the end which is near where we are at today for L.
The needed manufacturing breakthrough for L and the expected demand from both primary and rGBM along with very strong platform value with validation will make even those $12 shares look cheap in the next few years as the potential becomes not only understood but reality in whatever form the future of NWBO takes. That is a reality that many have not yet grasped but those who want cheap shares have and they will wait us out or we will stick it to them for even trying. Best wishes.
News 
Market Data 
Discover 
AI
